Next Article in Journal
Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects
Next Article in Special Issue
Exploring Anatomo-Morphometric Characteristics of Infrapatellar, Suprapatellar Fat Pad, and Knee Ligaments in Osteoarthritis Compared to Post-Traumatic Lesions
Previous Article in Journal
Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial–Myometrial Interface Disruption in Mice
Previous Article in Special Issue
Relationship between Lung and Brain Injury in COVID-19 Patients: A Hyperpolarized 129Xe-MRI-based 8-Month Follow-Up
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical Exchange Saturation Transfer (CEST) Signal at −1.6 ppm and Its Application for Imaging a C6 Glioma Model

1
Department of Chemistry and Biochemistry, National Chung Cheng University, Chiayi 62102, Taiwan
2
Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
3
Center for Nano Bio-Detection, National Chung Cheng University, Chiayi 62102, Taiwan
*
Author to whom correspondence should be addressed.
Submission received: 15 April 2022 / Revised: 17 May 2022 / Accepted: 21 May 2022 / Published: 24 May 2022

Abstract

:
The chemical exchange saturation transfer (CEST) signal at −1.6 ppm is attributed to the choline methyl on phosphatidylcholines and results from the relayed nuclear Overhauser effect (rNOE), that is, rNOE(−1.6). The formation of rNOE(−1.6) involving the cholesterol hydroxyl is shown in liposome models. We aimed to confirm the correlation between cholesterol content and rNOE(−1.6) in cell cultures, tissues, and animals. C57BL/6 mice (N = 9) bearing the C6 glioma tumor were imaged in a 7 T MRI scanner, and their rNOE(−1.6) images were cross-validated through cholesterol staining with filipin. Cholesterol quantification was obtained using an 18.8-T NMR spectrometer from the lipid extracts of the brain tissues from another group of mice (N = 3). The cholesterol content in the cultured cells was manipulated using methyl-β-cyclodextrin and a complex of cholesterol and methyl-β-cyclodextrin. The rNOE(−1.6) of the cell homogenates and their cholesterol levels were measured using a 9.4-T NMR spectrometer. The rNOE(−1.6) signal is hypointense in the C6 tumors of mice, which matches the filipin staining results, suggesting that their tumor region is cholesterol deficient. The tissue extracts also indicate less cholesterol and phosphatidylcholine contents in tumors than in normal brain tissues. The amplitude of rNOE(−1.6) is positively correlated with the cholesterol concentration in the cholesterol-manipulated cell cultures. Our results indicate that the cholesterol dependence of rNOE(−1.6) occurs in cell cultures and solid tumors of C6 glioma. Furthermore, when the concentration of phosphatidylcholine is carefully considered, rNOE(−1.6) can be developed as a cholesterol-weighted imaging technique.

1. Introduction

Metabolite-weighted magnetic resonance imaging (MRI) can be performed based on chemical exchange saturation transfer (CEST), which allows us to monitor muscle [1], the liver [2], ischemic stroke [3], and cancers [4,5,6]. A CEST effect relies on the radiofrequency (RF) pulse to saturate protons at varying frequency offsets, which usually range between −5 and 5 ppm relative to water resonance. When the exchangeable protons (e.g., amide, amine, and hydroxyl) on metabolites are saturated, the magnitude of a water signal can be reduced through the exchange of protons between water molecules and metabolites. With this saturation and exchange mechanism, metabolites and other biomolecules (in the millimolar concentration range) can be indirectly detected by reducing the water signal [7,8].
The effects of CEST can be plotted on a z-spectrum, in which the x-axis indicates the saturation offsets that are based on a water resonance of 0 ppm, and the y-axis indicates the magnitude of saturation at an offset as obtained by normalizing the intensity of water resonance to an unsaturated level [7,8]. However, a z-spectrum is highly subject to interference from direct water saturation and magnetization transfer (MT), which are usually more substantial than CEST dips. Researchers have proposed several methods for removing the background signals in CEST through pulse sequences (e.g., chemical exchange rotational transfer (CERT) [9,10,11] and variable delay multi-pulse (VDMP) [12,13]) or numerical methods (asymmetric MT [1,6,7,14,15], extrapolated semisolid magnetization transfer reference (EMR) [15,16], and deconvolutions with one or multiple Lorentzian functions [2,17,18,19,20,21,22]). These procedures are crucial for small CEST signals [17], such as the relayed nuclear Overhauser effect at −1.6 ppm, that is, rNOE(−1.6) [9,17,19,20,21,23,24,25,26].
The nuclear Overhauser effect (NOE) is caused by the cross-relaxation of nuclear spins, which results from the interactions between nuclear dipoles. NOEs can only be observed when the distance between two protons is sufficiently close (approximately < 5 Å) [27], and connections through chemical bonds are not required. When an unexchangeable proton is saturated, its neighboring protons can also be saturated through an NOE network. Because exchangeable protons are saturated through NOEs, bulk water can be saturated via the proton exchange last. This entire process is called relayed NOE (rNOE) [28]. The most prominent rNOE occurs at −3.5 ppm, and it is attributed to aliphatic protons. Although the rNOE at −3.5 ppm has less chemical specificity, it can be utilized to identify brain tumors [18,22,23,29]. By contrast, other rNOEs have a higher specificity, including the down-field rNOE at 3.5 ppm that is attributed to aromatic protons [30] and the rNOE at −1 ppm that is attributed to glycoNOE [2]. The rNOE(−1.6) was first revealed to be diminished in a 9L rat brain tumor model [9] and an ischemic stroke rat model [24]. The chemical origin of rNOE(−1.6) is presumably the choline methyl protons on phosphatidylcholines. The choline methyl group lacks exchangeable protons, and therefore the rNOE pathway can only be completed through the hydroxyls from nearby cholesterols. This dependence on cholesterols to form rNOE(−1.6) was observed in liposome models [25,26].
Approximately 20–25% of lipids in cell membranes are cholesterols [31], and therefore, the demand for cholesterol is high during the proliferation and progression of tumor cells [32,33,34]. Cholesterols can assemble with sphingomyelins to form lipid rafts on cell membranes such that the activity levels of membrane proteins could be regulated. For instance, the serine/threonine protein kinase, Akt, which is crucial to apoptosis and abnormal growth, is activated through an association with the lipid rafts [35,36]. Numerous hormones or oxysterols that are essential to promoting tumor growth (e.g., estrogen, progestogen, 24-hydroxylchoeslterol, and 27-hydroxylchoeslterol) utilize cholesterols as precursors [32,33]. The cholesterol homeostasis that occurs in the brain is a unique process. The blood–brain barrier blocks the cholesterol synthesized from the liver, and hence the synthesis of cholesterol primarily relies on the astrocytes in the brain [37,38]. Excess cholesterol in the brain is delivered to the peripheral system through high-density lipoproteins. Glioma cells have been demonstrated to detour around de novo cholesterol synthesis and to obtain cholesterols by upregulating low-density lipoprotein (LDL) receptors to uptake cholesterol from nearby astrocytes [38].
Numerous studies have suggested that rNOE(−3.5) imaging can be used to identify tumor regions [18,22,23,29]; however, rNOE(−3.5) may have a limited chemical/metabolic specificity. By contrast, rNOE(−1.6) originates from the choline methyls on phosphatidylcholines and requires the hydroxyl in cholesterol [26]. This unique mechanism can reveal the alternation that occurs within biological membranes and provide specific insights at the molecular level. The present study integrated the rNOE(−1.6) images obtained from mice, the cholesterol staining of brain sections, and the rNOE(−1.6) signals from cell homogenates. Additionally, the cholesterol content of the lipid extracts of tissues and cell homogenates was quantified through 1H nuclear magnetic resonance (NMR). On the basis of the results for the C6 cell cultures and C6 gliomas obtained from mice brains, the experiments of the present study were conducted to establish a foundation for cholesterol-weighted imaging.

2. Method

2.1. Cell Cultures, Homogenates, and Lipid Extraction

C6 cells were cultured using Dulbecco’s Modified Eagle’s Medium (DMEM, D7777, Sigma-Aldrich, Saint Louis, MO, USA) buffer with an additional 10% fetal bovine serum (TMS-013-BKR, Merck, Darmstadt, Germany) and 1% penicillin-streptomycin (P0781, Sigma-Aldrich, Saint Louis, MO, USA) at 37 °C with 5% CO2. The cell cultures generally required three to four days to reach 70% confluence. Approximately 8 × 107 cells were required to prepare a phantom of cell homogenates. Two solutions were prepared to manipulate the cholesterol content in the cell cultures [39,40], namely (1) a methyl-β-cyclodextrin (MβCD, 332615, Sigma-Aldrich, Saint Louis, MO, USA) solution (500 mM in phosphate-buffered saline [PBS] buffer) for cholesterol-depletion experiments and (2) a chol-MβCD solution comprising 85% (v/v) MβCD solution (240 mM in PBS) and 15% (v/v) cholesterol solution (25 mg/mL in ethanol) for cholesterol-enrichment experiments.
Each cultured medium was removed and washed with PBS twice before cholesterol manipulation. A total of 10 mL of fresh DMEM was added together with an additional 200 μL of MβCD solution and 250 μL of chol-MβCD solution for cholesterol depletion and enrichment, respectively; the control group was treated with 10 mL of fresh DMEM. Each group was cultured at 37 °C for 30 min and subsequently detached with trypsin (15090-046, ThermoFisher, Waltham, MA, USA). The harvested cells were washed with PBS twice and collected through centrifugation. Each cell pellet was resuspended in 1 mL of deionized water and frozen in liquid nitrogen to lyse the cells. Cell debris was homogenized in an ice bath by using a sonicator (20 s on and 20 s off for 3 cycles). The homogenates were lyophilized and subsequently resuspended in 405 μL of PBS and 45 μL of D2O (151882, Sigma-Aldrich, Saint Louis, MO, USA) to allow for T1 and CEST measurements.
Cholesterol concentration was estimated by examining the lipid extracts of the cell homogenates [41]. After the T1 and CEST experiments were completed, the cell homogenates were removed from the NMR tubes that they were housed in and lyophilized. In total, 200 μL of methanol and 85 μL of deionized water were added to the dried homogenates, and the resulting solution was sonicated (20 s on and 20 s off for 5 cycles). Next, 200 μL of chloroform was added to the methanol–water solution, which was then vortexed for 2 min. Finally, 200 μL of chloroform and 200 μL of water were added to the resulting solution, which was vortexed again for 2 min. The organic/aqueous mixture was cooled in an ice bath for 10 min and centrifuged for 15 min at 12,000× g and 4 °C. The organic layer was carefully transferred out, and the organic solvent was removed using N2 streams and lyophilization. The sample was redissolved in 450 μL of D-chloroform (612200, Sigma-Aldrich, Saint Louis, MO, USA) to prepare them for 1H NMR measurements.

2.2. Animals, Section Staining, and Tissue Extraction

The procedures for performing animal experiments were approved by the Institute of Animal Care and Utilization Committee of Academia Sinica, Taipei, Taiwan (protocol code number: 17-02-1050 and the approved date: 25 Auguest 2021). C57BL/6 male mice (6 weeks old) were purchased from BioLASCO (Taiwan) and raised with free access to water and food on a 12-h day/12-h night cycle. In total, 5 × 105 C6 cells suspended in 2 μL of PBS buffer were injected into the right hemisphere at a flow rate of 500 nL/min to establish a tumor model. The mice were imaged three days after the aforementioned surgery.
The mice were anesthetized with 0.16 mL of a solution comprising Zoletil 50 (sagarpa-Q-0042-058, Virbac, Carros, France), Xylazine (08443, Elite Bio-Science, New Orleans, LA, USA), and saline at a volume ratio of 1:2:12 to prepare the brain section. The mice were perfused with saline until the resulting effluent was clear, and they were then perfused with 20 mL of 4% paraformaldehyde (PFA, 158127, Sigma-Aldrich, Saint Louis, MO, USA). Each mouse brain was removed and immersed in 4% PFA at 4 °C for one day, after which it was transferred to a 20% sucrose solution followed by a 30% sucrose solution to prevent the formation of ice crystals that can damage tissue morphology. Finally, 20-μm tissues were obtained through frozen sectioning. The optimal cutting temperature compound (4583, Sakura, Torrance, CA, USA) that was used during the sectioning procedure was removed by using PBS before staining. Each tissue section was immersed in a hematoxylin buffer (HHS16, Sigma-Aldrich, Saint Louis, MO, USA) for 5 min, differentiated with acid alcohol, and washed with water. A four-percent PFA solution was used to fix the section, and the excess PFA was removed by immersing the section in PBS for 5 min and in glycine (G7403, Sigma-Aldrich, Saint Louis, MO, USA) for another 5 min. Each section was covered with a 0.1-mL filipin (F4767, Sigma-Aldrich, Saint Louis, MO, USA) solution for 2 h in a dark environment for cholesterol staining [42,43]. Excess filipin solution was removed by immersing each section in fresh PBS buffer for 3 min twice. Each section was then sealed with CC/mount medium (C9368, Sigma-Aldrich, Saint Louis, MO, USA).
Mouse brains were removed immediately following scarification on days nine and 12, and the tumor and normal parts of each brain were separated visually. These tissues were prepared for the lipid extraction of tissues. The wet weights of tumor and normal tissues ranged between 3.2 and 28.7 mg and between 26.1 and 42.9 mg, respectively. These tissues were subsequently vortexed in an iced solution (4 mL of methanol per gram of tissue and 0.85 mL of water per gram of tissue) until the solution became homogenous. The solution was then vortexed with an additional 2 mL of chloroform per gram of tissue. Finally, 2 mL of chloroform per gram of tissue and 2 mL of water per gram of tissue were added to the solution, which was then vortexed. The organic/aqueous mixture was cooled down in an ice bath for 10 min and then centrifuged for 15 min at 12,000× g and 4 °C. The organic layer was carefully transferred out, and the organic solvent was removed through N2 streams and lyophilization. The dried extracts, which were each equivalent to 1.2 mg of wet tissue in weight, were redissolved in 550 μL of D-chloroform (DLM-7TB, Cambridge Isotope Laboratories, Tewksbury, MA, USA) for 1H NMR experimentation.

2.3. MRI

The images were obtained using a 7-T Bruker BioSpec 70/20 USR system equipped with an RF transmit coil (RF RES 300 1H 112/086 QSN TO AD) and a receiver coil (RF ARR 300 1H M.BR. 2 × 2 RO AD). For all images, a readout sequence of rapid imaging with refocused echoes (RAREs) was utilized, with the field of view being 16 × 16 mm2, slice thickness being 2 mm, and average being 1. A T1 map was generated using the sequence “RARE VTR” with a RARE factor of 3; TE of 14 ms; TR values of 50, 200, 500, 800, 1000, 2000, 4000, and 6000 ms; and a matrix size of 128 × 64. CEST and water saturation shift referencing (WASSR) [44] images were acquired with a dummy scan of 4, RARE factor of 16, TE/TR of 42.07/5000 ms, and matrix size of 128 × 64. For the WASSR experiments [44], the saturation duration and a saturation amplitude were 4 s and 0.1 μT, respectively. The saturation offsets were between −1 and 1 ppm (with a 0.1-ppm increment). The saturation duration was 4 s, and saturation amplitudes were 0.3, 0.6, and 0.9 μT. The saturation offsets were 333, −10, −8, −6, −5, −4 to 4 (with a 0.1-ppm increment), 5, 6, 8, and 10 ppm.

2.4. NMR

The z-spectra of cell homogenates were measured using a Bruker 400-MHz (9.4 T) AVIII spectrometer and a BBO 400-MHz S1 5-mm probe with a z-gradient. The T1 values of the homogenates were measured using the inversion-recovery sequence t1ir, and the following parameters were applied: spectral width = 7.5 ppm, number of sampling points = 16,384, acquisition time = 2.7 s, recycle delay = 5 s, dummy scan = 4, and signal average = 4. The durations of inversion recovery were 0.01, 0.05, 0.1, 0.25, 0.5, 1, 2, 4, 6, and 10 s. The CEST results pertaining to the cell homogenates were obtained using the sequence stddiff, and the following acquisition parameters were applied: spectral width = 10 ppm, number of sampling points = 11,998, acquisition time = 1.5 s, recycle delay = 2 s, dummy scan = 4, signal average = 1. The saturation amplitudes were 0.3, 0.6, and 0.9 μT, and the saturation duration was 5 s. For the CEST experiments, the saturation offsets were implemented as follows: 250, −20, −15, −10, −6, −5, −4.5, −4 to −3 (with a 0.1-ppm increment), −2.8 to −2 (with a 0.2-ppm increment), −1.9 to −1 (with a 0.1-ppm increment), −0.8 to 4 (with a 0.2-ppm increment), 4.5, 5, 6, 10, 15, and 20 ppm. The 1H spectra of the homogenate extracts were acquired using the sequence zg30, and the following parameters were applied: spectral width = 20 ppm, number of sampling points = 32,768, acquisition time = 2 s, recycle delay = 2 s, and signal average = 64.
The 1H spectra of the tissue extracts were obtained using an Avance 800 MHz spectrometer and a TX1 5-mm CryoProbe probe with a z-gradient by using the following parameters: spectral width = 14 ppm, number of sampling points = 32,768, acquisition time = 1.46 s, recycle delay = 2 s, and signal average = 512.

2.5. Data Processing

2.5.1. MRI

The T1 value of each voxel was determined using the saturation recovery function as follows:
I ( t ) = I 0 ( 1 exp ( t / T 1 ) ) ,
where I(t) is the measured intensity of a pixel with a recovery delay of t, and I0 is the intensity of a pixel with no recovery delay. B0 correction was performed using the WASSR method [44], in which a Lorentzian function was fitted to the saturation spectrum, and the B0 offset was determined by obtaining the center of the fitted Lorentzian function. The CEST images were normalized to the image measured at 333 ppm and subsequently smoothed using a 3 × 3 median filter. A total of 25 voxels from normal regions and another 25 voxels from tumor regions were selected and averaged to obtain the representative z-spectra of each animal. The interferences from water, MT, and T1 were minimized by employing the residuals of apparent exchange-dependent relaxation rate (AREXresid) [17,18,19,20,21,22]. In brief, AREXresid was obtained using the inversed residue between the measured z-spectrum (Smeas) and fitted z-spectrum (Sfit), which was corrected by T1 and the pool size of MT (fm); the equation for obtaining AREXresid is as follows:
A R E X r e s i d ( Δ ω ) = ( S 0 S m e a s ( Δ ω ) S 0 S f i t ( Δ ω ) ) × 1 T 1 ( 1 + f m ) .
where S0 is the normalizer, and ∆ω is the saturation offset. The obtained AREXresid(−3.5) was further isolated using a Gaussian function centered at approximately −3.5 ppm; the area under the curve (AUC) of the Gaussian function was referred to as the size of AREXresid(−3.5). The residual signals from Gaussian deconvolution were summed, determined to be between −1.3 and −1.9 ppm, and used as the AUC of AREXresid(−1.6). The fitting procedures that were performed for AREXresid and AREXresid(−3.5) isolation are described in detail in the Supplementary Materials.

2.5.2. NMR

The inversion recovery curve for the cell homogenates indicated the presence of multiple T1 relaxations. Therefore, we fitted the normalized recovery curve by applying the following equation (which includes two T1s):
I ( t ) = 1 2 ( x a exp ( t T 1 , a ) + ( 1 x a ) exp ( t T 1 , b ) )
where T1,a and T1,b are the T1 relaxations for pools a and b, respectively, and xa is the portion of the pool a. The averaged T1 in Equation (4) is the T1 for a cell homogenate. Equation (4) is expressed as follows:
T 1 , a v g = x a T 1 , a + ( 1 x a ) T 1 , b
The z-spectra were obtained by normalizing the water resonance to the acquisition at 250 ppm. The AREXresid of the cell homogenates was obtained using Equation (2), and AREXresid(−1.6) and AREXresid(−3.5) were isolated using two Gaussian functions. The areas of these two Gaussian functions served as the AUCs of AREXresid(−1.6) and AREXresid(−3.5). The procedures that were performed for AREX correction and rNOE isolation (i.e., isolation from the AREX residual) are described in detail in the Supplementary Materials.

2.5.3. Cholesterol Quantification through 1H NMR

The D-chloroform solvent contained internal standard tetramethylsilane (TMS) at a concentration of 0.05% v/v (3.67 mM). The AUC of 1H NMR resonance was assumed to be proportional to its concentration. Therefore, cholesterol concentration was estimated by comparing the AUC of cholesterol methyl (0.68 ppm) to that of TMS at 0 ppm.

3. Results

The average z-spectra (N = 9) that was measured at four days at a saturation amplitude of 0.9 μT are plotted in Figure 1, in which the normal and tumor sides are represented by the blue and red regions, respectively. The z-spectra obtained at saturation amplitudes of 0.3 and 0.6 μT are plotted in Figure S1. Typical features were identified in the distinct amide (3.5 ppm), amine (2 ppm), and rNOE (−3.5 ppm) dips and the MT background. A minor absorption appeared on the shoulder of the direct saturation at −1.6 ppm, and it was referred to as the choline group from lipids. The normal side had a higher saturation than the tumor side [9,19,25], and this difference increased during the experimental period.
The region of negative offset in the z-spectra is expanded in Figure 2A–D, and the same region of AREXresid is plotted in Figure 2E–H. To further elucidate the changes to AREXresid(−1.6), a Gaussian function was fitted to the average AREXresid centered at approximately −3.5 ppm. In Figure 2I–L, AREXresid(−3.5) is indicated by dashed lines, and the residuals are indicated by solid lines. These residuals contain a signal that was approximately between −2 and −1 ppm. The information on AREXresid(−3.5) and AREXresid(−1.6) that is plotted in Figure 2 is further organized in Figure 3A,B. The amplitudes of AREXresid(−3.5) and AREXresid(−1.6) on the normal side remained mostly unchanged between days three and 12; however, the amplitudes of AREXresid(−3.5) and AREXresid(−1.6) on the tumor side were lower on days 9 and 12. The AREXresid values at −1.6 and −3.5 ppm indicated a significant difference (p < 0.05 or 0.001) between the normal and tumor tissues on days nine and 12. The AUCs of AREXresid(−3.5) and AREXresid(−1.6) were greater on the normal side than on the tumor side, and the AUC of AREXresid(−1.6) tended to decrease during the growth of the tumor (Figure 3C,D). However, these AUCs were obtained from averaged AREXresid values, and we could not analyze the difference between the tissues and the longitudinal changes to the statistical metrics.
Additional mice were sacrificed on days 3, 6, 9, and 12 to correlate the AREXresid(−1.6) images with the staining images. The AREXresid(−1.6) images are shown in Figure 4A–D, and they indicate that rNOE(−1.6) was hypointense in the tumor region, particularly on days 9 and 12. The brain sections were stained using hematoxylin (Figure 4E–G) and filipin (Figure 4I–L). For hematoxylin staining, the dense region of nuclei (which indicate tumors [45,46]) approximately coincides with the tumor region from the rNOE(−1.6) images. The filipin staining results further suggest that the C6 tumor region was cholesterol deficit [42]. The T2-weighted, T1 map, MT, and AREXresid (at 3.5, 2, −1.6, and −3.5 ppm) images obtained from these mice are shown in Figure S2.
Cholesterol quantification was performed using another set of mice (N = 3), specifically the 1H NMR spectra of their brain extracts. Compared with standard cholesterol spectra (Figure S3A,B), the peaks at 1.00 and 0.68 ppm can be attributed to the presence of sterol methyls in the cholesterol. The resonance at 0.68 ppm (Figure 5A,B) was lower in tumors than in normal tissues. The whole spectra of the lipid extracts are presented in Figure S3C–F. We utilized the AUCs of cholesterol methyl (at 0.68 ppm) to estimate the cholesterol content in the tissue data plotted in Figure 5C. A significant difference (p < 0.05) in cholesterol content was identified between normal and tumor tissues, but no significant change was detected longitudinally. The 1H spectra (Figure 5D) from the tumor and normal extracts could also reveal the lipid composition, in which the peaks located around 3.35 and 1.5 ppm can be attributed to choline methyls from the phosphatidylcholines and alkyl hydrogens [47]. Figure 5E shows that the relative contents of phosphatidylcholines were lower in tumors than in normal tissues based on the integration from 3.28 to 3.38 ppm. The amounts of total lipid estimated based on the alkyl hydrogens (from 1.45 to 1.65 ppm) were roughly the same in tumors and normal tissues (Figure 5F).
The CEST experimental results for the cell homogenates measured at a 0.9-μT saturation amplitude are presented in Figure 6A. The magnitude of the rNOE dips in the z-spectra increases with cholesterol content (i.e., cholesterol enrichment > control > cholesterol depletion). The full z-spectra of the cell homogenates obtained at amplitudes of 0.3 and 0.6 μT are presented in Figure S4. Figure 6B reveals a positive correlation between the amplitude of rNOE(−1.6) and cholesterol content remains on the basis of the AREXresid metric. The deconvoluted AREXresid that used two Gaussian functions indicated that AREXresid(−3.5) and AREXresid(−1.6) were both dependent on the level of cholesterol content (Figure 6C). The z-spectra and AREXresid results pertaining to the amides and amines that responded to cholesterol manipulation are presented in Figure 6D,E, respectively. The deconvolutions of the amide and amine pools in AREXresid are presented in Figure 6F.
Figure 7A presents the spectra of cholesterol methyl at 0.68 ppm, and it indicates that cholesterol depletion and enrichment change the cholesterol concentration in cell cultures. The cholesterol concentration results indicated a linear correlation between the AUCs of AREXresid(−3.5) and AREXresid(−1.6) (Figure 7B,C). The linear regressions between cholesterol concentration and amides, amines, and rNOE at −1.6 and −3.5 ppm are listed in Table 1, and they suggest that amides, amines, and rNOE(−3.5) are slightly influenced by cholesterol concentration. The full 1H NMR spectra of the lipid extracts from the cell homogenates used in the CEST experiments are presented in Figure S5.

4. Discussion

Glutamate [3,14], creatine [1,4], and glucose [5,6]-weighted images can be generated using CEST techniques. These biomolecules are usually small and hydrophilic. Large hydrophilic biomolecules such as glycogen [2,48] can also be imaged using CEST techniques. Hydrophobic biomolecules are usually buried in biological membranes, in which molecular motions are hindered by surrounding lipids, resulting in a short molecular T2; furthermore, water accessibility can be highly reduced for molecules that are associated with membranes. These factors are deleterious to the formation of a CEST signal. The CEST signals that are related to the hydrophobic part of biomolecules are usually regarded as nonspecific (e.g., MT or rNOE at −3.5 ppm), and the studies of detecting hydrophobic molecules through CEST are still limited.
rNOE(−1.6) is specific to the choline in phosphatidylcholines; thus, it offers an opportunity to observe the changes that occur in biological membranes. A reduction of rNOE(−1.6) was detected in the brain tumor and stroke regions of the examined rats [9,24]. The liposome models indicated the presence of rNOE(−1.6) in cholesterol [25,26] and that the length and saturation degree of the hydrocarbon chains in phosphatidyl lipids were only slightly influenced by the magnitude of rNOE(−1.6) [25]. The hydroxyl in cholesterol was also revealed to be required for chemical exchanges [26]. However, the biological membranes comprised highly diverse lipids (including phosphatidylcholines) [49] and membrane proteins, and these components could influence the magnitude of rNOE(−1.6). The correlation between cholesterol content and rNOE(−1.6) in the biological models was not supported by direct evidence.
The amplitudes of rNOE(−1.6) in the z-spectra and AREXresid were reduced on the tumor side (Figure 1, Figure 2 and Figure 3); this finding is consistent with those reported by other studies [9,19,25]. Figure 4 presents the AREXresid(−1.6) images and the hematoxylin and filipin staining results together; they indicate that the tumor region was cholesterol-deficit and that the AREXresid(−1.6) in the tumor region was hypointense. We further demonstrated that the cholesterol concentration in the extracted tumors was lower than that in the normal tissues (Figure 5). A similar phenomenon was observed in the infrared images of the C6 tumors in rat brains in the literature [50], which had a higher cholesterol level in the peritumor region than in the tumor region. With respect to the cholesterol deficiency in the tumor region, our AREXresid(−1.6) images and filipin staining results are consistent with the infrared images produced in the literature [50]. Moreover, the average AREXresid(−1.6) (Figure 3B) and cholesterol quantification (Figure 5C) results did not reveal a significant longitudinal difference in the tumor region. These results indicated that glioma cells suppress their cholesterol synthesis pathway and uptake cholesterol through the LDL from nearby astrocytes [38].
We further verified the dependence of AREXresid(−1.6) on the cholesterol in C6 cell cultures (Figure 6), in which cholesterol levels can be reduced or increased by using MβCD or chol-MβCD solutions, respectively. The change in cholesterol level was verified through 1H NMR spectroscopy (Figure 7). The AREXresid(−1.6) of the cell homogenates has a positive correlation with cholesterol concentration, indicating that cholesterol enhanced the rNOE(−1.6) in the biological-derived samples; this finding is similar to that obtained from model liposomes [25,26]. This finding also supports the hypothesis that cholesterol increases the rNOE(−1.6) in animal models.
The experiments of cell homogenate suggested that in addition to rNOE(−1.6), other apparent CEST signals (rNOE(−3.5), amide, and amine) had positive correlations with cholesterol content (Figure 6, Figure 7 and Figure S4; Table 1). The cavity enclosed by MβCD can accommodate a cholesterol molecule. Therefore, the magnitude of rNOE(−1.6) is presumably influenced by the cholesterol depletion and enrichment through MβCD and chol-MβCD, respectively. The cholesterol dependency of rNOE(−3.5) was reported by other studies, and it could be a result of the change in the order or fluidity of membranes [25,26]. Similarly, a low cholesterol dependency of amides and amines could be due to the membranes associated with biomolecules (e.g., membrane proteins). The amount of cholesterol (Figure 5) and the magnitudes of rNOE (Figure 3A,B) were also positively correlated with the animal models. Through our current protocol, we could visually separate the normal and tumor tissues when a tumor was sufficiently large. Therefore, we only obtained the lipid extracts on days nine and 12, which prevented us from performing an appropriate regression analysis of the association between cholesterol content and rNOE amplitude in the tissue studies. Also, in order to obtain the largest possible tumor tissues for the extraction, some of the surrounding normal tissues might not be fully removed. This contamination from the normal tissues is presumably increasing the cholesterol concentration of the tumor tissues. It might explain that the cholesterol concentration was roughly the same in the tumors between days nine and 12 (Figure 5C) instead of showing a decreasing trend (Figure 2K,L and Figure 3D).
Although we consistently found the cholesterol dependency of rNOE(−1.6), the 1H resonance suggests that the amounts of phosphatidylcholine were reduced in the tumors (Figure 5E), which was also found in the studies using infrared images [50]. Meanwhile, the amounts of total lipids remain roughly the same in tumor and normal tissues (Figure 5F). It suggests that both the cholesterol and phosphatidylcholine contents were reduced in the membranes of the tumor. The rNOE(−1.6) originates from the saturation of the choline methyls from the phosphatidylcholines, and hence the rNOE(−1.6) reduction in the glioma model might not be solely dependent on the cholesterol content. The reduction of rNOE(−1.6) was also observed in the ischemic stroke rat model [24], and the mechanism is unclear. We are not aware of a study showing the change in the cholesterol content during the period of ischemic stroke. However, it has been reported that the formation of free radicals could oxidize the lipid during ischemic stroke [51]. The change in the lipid compositions could be the possible source of reducing rNOE(−1.6).
Among the CEST effects, the magnitude of rNOE(−1.6) was small, and multiple-step processing was required to extract this information. In the present study, we used the AREXresid metric suggested by Zu [17] that the direct water saturation and MT is removed by a two-pool Lorentzian model, and the influence of water T1 is minimized by using the AREX method. Through the removal of rNOE(−3.5) from averaged residual rNOEs, the changes at approximately −1.6 ppm can be observed. However, our results were still considerably influenced by our choice of fitting conditions. For instance, the baseline of rNOE(−1.6) could be negative if the range of direct saturation was overestimated. With our fitting condition, the potential glycoNOE2 at −1 ppm was difficult to verify in AREXresid. Furthermore, the harvested cell cultures contained excess water, resulting in a considerable variation in wet weight, such that we had to quantify cholesterol by concentration per sample instead of cholesterol weight per unit of cell wet weight. Therefore, although we discovered a correlation between cholesterol content and rNOE(−1.6), we still lacked a quantified index that was appropriate for pathological evaluation. We attempted to integrate the results obtained from various experiments. Limits in experimental design meant that three groups of mice were required, specifically for CEST and MRI imaging (N = 9), tissue staining (N = 1), and tissue extraction (N = 3), all of which introduced additional variations.
Monitoring the cholesterol homeostasis usually relies on the expression levels of the associating biomarker. For instance, the down-regulated LDL receptor (LDLR) and upregulated ABCA1 (ATP Binding Cassette Subfamily A Member 1) suggest that depleting cholesterol results in the vulnerable glioma cells [38]. Aside from cancer therapies [34,37,38], cholesterol metabolism is also essential to the neurodevelopment [52,53] and neurodegeneration [54,55]. The cholesterol-related activities can be monitored by the expression level of the associated proteins, including LRPs (low-density lipoprotein receptor-related proteins), uptaking LDL [52,53,54], or BMPs (bone morphogenetic proteins), signaling the cholesterol synthesis [55]. However, the techniques to evaluate the expression levels of cholesterol-associated biomarkers are usually only available for the cell cultures or ex vivo samples. Developing the in vivo imaging technique reflecting the cholesterol content is still needed. We hope that rNOE(−1.6) imaging could provide complementary information to the existing methods with the dependency on cholesterol.

5. Conclusions

Studies have suggested that interference with cholesterol homeostasis or metabolism is an effective therapy for brain cancer. However, an in vivo technique for imaging cholesterol has yet to be developed. We verified the positive correlation between cholesterol content and rNOE(−1.6) through multiple methods, including in vivo animal imaging, histology staining, use of cell homogenates, and tissue and homogenate extraction. However, the concentration of phosphatidylcholine also showed a positive correlation with rNOE(−1.6). Our studies suggest that the decreasing rNOE(−1.6) in the C6 glioma results from reduced cholesterol and phosphatidylcholine concentrations. Hence, it still requires more quantitative studies to reveal the meaning of the rNOE(−1.6) image at the molecular level.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/biomedicines10061220/s1, Figure S1: Average z-spectra from normal and tumorous brain as measured on day 12 with various saturation amplitudes; Figure S2: T2-weighted, T1 Map, MT, and AREXresid (at 3.5, 2, −1.6, and −3.5 ppm) images of the mice shown in Figure 4; Figure S3: Averaged 1H NMR spectra from the normal and tumorous brain tissues; Figure S4: Average z-spectra from cholesterol-depleted, control, and cholesterol-enriched cell homogenates with various saturation amplitudes; Figure S5: Averaged 1H NMR spectra from cholesterol-depleted, control, and cholesterol-enriched cell homogenates.

Author Contributions

Conceptualization, E.C.L.; Data curation, Q.-X.W., Y.-J.W., T.-C.C. and Z.-Y.W.; Formal analysis, Q.-X.W., Y.-J.W. and E.C.L.; Methodology, Q.-X.W., H.-Q.L., Y.-J.W., T.-C.C., J.-H.C., T.-H.C. and J.S.; Resources, E.C.L.; Supervision, E.C.L.; Writing — Original draft, E.C.L.; Writing — Review & editing, E.C.L. All authors have read and agreed to the published version of the manuscript.

Funding

Ministry of Science and Technology of Taiwan (MOST): 109-2113-M-194-010-MY3.

Institutional Review Board Statement

The animal study protocol was approved by the Institute of Animal Care and Utilization Committee of Academia Sinica (protocol code 17-02-1050 on 25 August 2021) for studies involving animals.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Acknowledgments

This study is supported by the Advanced Institute of Manufacturing with High-tech Innovations (AIM-HI) from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. We thank the Animal Imaging Facility at Academia Sincia, for its excellent assistance with the MRI scanning. We thank Academia Sinica High-Field NMR Center (HFNMRC) for technical support; HFNMRC is funded by Academia Sinica Core Facility and Innovative Instrument Project (AS-CFII-111-214). We also thank Guor-Tzo Wei and Yu-Jie Huang for the optimization of cholesterol quantification.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kogan, F.; Stafford, R.B.; Englund, E.K.; Gold, G.E.; Hariharan, H.; Detre, J.A.; Reddy, R. Perfusion has no effect on the in vivo CEST effect from Cr (CrCEST) in skeletal muscle. NMR Biomed. 2016, 30, e3673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Zhou, Y.; van Zijl, P.C.M.; Xu, X.; Xu, J.; Li, Y.; Chen, L.; Yadav, N.N. Magnetic resonance imaging of glycogen using its magnetic coupling with water. Proc. Natl. Acad. Sci. USA 2020, 117, 3144–3149. [Google Scholar] [CrossRef] [PubMed]
  3. Nicolo, J.-P.; Moffat, B.; Wright, D.K.; Sinclair, B.; Neal, A.; Lui, E.; Desmond, P.; Glarin, R.; Davis, K.A.; Reddy, R. 7T Magnetic Resonance Imaging Quantification of Brain Glutamate in Acute Ischaemic Stroke. J. Stroke 2021, 23, 281–284. [Google Scholar] [CrossRef] [PubMed]
  4. Cai, K.; Tain, R.-W.; Zhou, X.J.; Damen, F.C.; Scotti, A.M.; Hariharan, H.; Poptani, H.; Reddy, R. Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness. Mol. Imaging Biol. 2017, 19, 225–232. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Xu, X.; Chan, K.W.; Knutsson, L.; Artemov, D.; Xu, J.; Liu, G.; Kato, Y.; Lal, B.; Laterra, J.; McMahon, M. Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer. Magn. Reson. Med. 2015, 74, 1556–1563. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Walker-Samuel, S.; Ramasawmy, R.; Torrealdea, F.; Rega, M.; Rajkumar, V.; Johnson, S.P.; Richardson, S.; Gonçalves, M.; Parkes, H.G.; Arstad, E. In vivo imaging of glucose uptake and metabolism in tumors. Nat. Med. 2013, 19, 1067–1072. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. van Zijl, P.C.M.; Yadav, N.N. Chemical exchange saturation transfer (CEST): What is in a name and what isn’t? Magn. Reson. Med. 2011, 65, 927–948. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Ward, K.; Aletras, A.; Balaban, R. A New Class of Contrast Agents for MRI Based on Proton Chemical Exchange Dependent Saturation Transfer (CEST). J. Magn. Reson. 2000, 143, 79–87. [Google Scholar] [CrossRef]
  9. Zu, Z.; Xu, J.; Li, H.; Chekmenev, E.; Quarles, C.C.; Does, M.D.; Gore, J.C.; Gochberg, D.F. Imaging amide proton transfer and nuclear overhauser enhancement using chemical exchange rotation transfer (CERT). Magn. Reson. Med. 2014, 72, 471–476. [Google Scholar] [CrossRef] [Green Version]
  10. Zu, Z.; Janve, V.A.; Xu, J.; Does, M.D.; Gore, J.C.; Gochberg, D.F. A new method for detecting exchanging amide protons using chemical exchange rotation transfer. Magn. Reson. Med. 2013, 69, 637–647. [Google Scholar] [CrossRef] [Green Version]
  11. Lin, E.C.; Li, H.; Zu, Z.; Louie, E.A.; Lankford, C.L.; Dortch, R.D.; Does, M.D.; Gore, J.C.; Gochberg, D.F. Chemical exchange rotation transfer (CERT) on human brain at 3 Tesla. Magn. Reson. Med. 2018, 80, 2609–2617. [Google Scholar] [CrossRef] [PubMed]
  12. Xu, X.; Yadav, N.N.; Zeng, H.; Jones, C.K.; Zhou, J.; van Zijl, P.C.M.; Xu, J. Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T. Magn. Reson. Med. 2015, 75, 88–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Xu, J.; Yadav, N.N.; Bar-Shir, A.; Jones, C.K.; Chan, K.W.; Zhang, J.; Walczak, P.; McMahon, M.; van Zijl, P.C.M. Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI. Magn. Reson. Med. 2014, 71, 1798–1812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Cai, K.; Haris, M.; Singh, A.; Kogan, F.; Greenberg, J.H.; Hariharan, H.; Detre, J.A.; Reddy, R. Magnetic resonance imaging of glutamate. Nat. Med. 2012, 18, 302–306. [Google Scholar] [CrossRef] [Green Version]
  15. Heo, H.-Y.; Jones, C.K.; Hua, J.; Yadav, N.; Agarwal, S.; Zhou, J.; Van Zijl, P.C.; Pillai, J.J. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T. J. Magn. Reson. Imaging 2015, 44, 41–50. [Google Scholar] [CrossRef]
  16. Heo, H.-Y.; Zhang, Y.; Jiang, S.; Lee, D.-H.; Zhou, J. Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla. Magn. Reson. Med. 2016, 75, 1630–1639. [Google Scholar] [CrossRef] [Green Version]
  17. Zu, Z. Toward more reliable measurements of NOE effects in CEST spectra at around −1.6 ppm (NOE (−1.6)) in rat brain. Magn. Reson. Med. 2019, 81, 208–219. [Google Scholar] [CrossRef] [Green Version]
  18. Goerke, S.; Soehngen, Y.; Deshmane, A.; Zaiss, M.; Breitling, J.; Boyd, P.S.; Herz, K.; Zimmermann, F.; Klika, K.D.; Schlemmer, H.P. Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T. Magn. Reson. Med. 2019, 82, 622–632. [Google Scholar] [CrossRef]
  19. Zu, Z. Ratiometric NOE(−1.6) contrast in brain tumors. NMR Biomed. 2018, 31, e4017. [Google Scholar] [CrossRef]
  20. Shah, S.M.; Mougin, O.E.; Carradus, A.J.; Geades, N.; Dury, R.; Morley, W.; Gowland, P.A. The z-spectrum from human blood at 7T. NeuroImage 2018, 167, 31–40. [Google Scholar] [CrossRef]
  21. Zhang, X.-Y.; Wang, F.; Jin, T.; Xu, J.; Xie, J.; Gochberg, D.F.; Gore, J.C.; Zu, Z. MR imaging of a novel NOE-mediated magnetization transfer with water in rat brain at 9.4 T. Magn. Reson. Med. 2017, 78, 588–597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Jones, C.K.; Huang, A.; Xu, J.; Edden, R.; Schär, M.; Hua, J.; Oskolkov, N.; Zacà, D.; Zhou, J.; McMahon, M.; et al. Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. NeuroImage 2013, 77, 114–124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Zaiss, M.; Schuppert, M.; Deshmane, A.; Herz, K.; Ehses, P.; Füllbier, L.; Lindig, T.; Bender, B.; Ernemann, U.; Scheffler, K. Chemical exchange saturation transfer MRI contrast in the human brain at 9.4 T. NeuroImage 2018, 179, 144–155. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, X.Y.; Wang, F.; Afzal, A.; Xu, J.; Gore, J.C.; Gochberg, D.F.; Zu, Z. A new NOE-mediated MT signal at around −1.6 ppm for detecting ischemic stroke in rat brain. J. Magn. Reson. Imaging 2016, 34, 1100–1106. [Google Scholar] [CrossRef] [Green Version]
  25. Zu, Z.; Lin, E.C.; Louie, E.A.; Xu, J.; Li, H.; Xie, J.; Lankford, C.L.; Chekmenev, E.Y.; Swanson, S.D.; Does, M.D. Relayed nuclear Overhauser enhancement sensitivity to membrane Cho phospholipids. Magn. Reson. Med. 2020, 84, 1961–1976. [Google Scholar] [CrossRef]
  26. Chang, Y.-L.C.; Liu, H.-Q.; Chang, J.-H.; Chang, Y.-Y.; Lin, E.C. Role of the cholesterol hydroxyl group in the chemical exchange saturation transfer signal at −1.6 ppm. NMR Biomed. 2020, 33, e4356. [Google Scholar] [CrossRef]
  27. Braun, W.; Gō, N. Calculation of protein conformations by proton-proton distance constraints: A new efficient algorithm. J. Mol. Biol. 1985, 186, 611–626. [Google Scholar] [CrossRef]
  28. van Zijl, P.C.; Zhou, J.; Mori, N.; Payen, J.F.; Wilson, D.; Mori, S. Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn. Reson. Med. 2003, 49, 440–449. [Google Scholar] [CrossRef]
  29. Liu, D.; Zhou, J.; Xue, R.; Zuo, Z.; An, J.; Wang, D.J.J. Quantitative characterization of nuclear overhauser enhancement and amide proton transfer effects in the human brain at 7 tesla. Magn. Reson. Med. 2013, 70, 1070–1081. [Google Scholar] [CrossRef] [Green Version]
  30. Zaiss, M.; Windschuh, J.; Goerke, S.; Paech, D.; Meissner, J.E.; Burth, S.; Kickingereder, P.; Wick, W.; Bendszus, M.; Schlemmer, H.P. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma. Magn. Reson. Med. 2016, 77, 196–208. [Google Scholar] [CrossRef]
  31. Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 2008, 9, 125–138. [Google Scholar] [CrossRef]
  32. Riscal, R.; Skuli, N.; Simon, M.C. Even Cancer Cells Watch Their Cholesterol! Mol. Cell 2019, 76, 220–231. [Google Scholar] [CrossRef] [PubMed]
  33. Kuzu, O.F.; Noory, M.A.; Robertson, G.P. The Role of Cholesterol in Cancer. Cancer Res. 2016, 76, 2063–2070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Xu, H.; Zhou, S.; Tang, Q.; Xia, H.; Bi, F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim. Biophys. Acta Rev. Cancer 2020, 1874, 188394. [Google Scholar] [CrossRef] [PubMed]
  35. Arcaro, A.; Aubert, M.; del Hierro, M.E.E.; Khanzada, U.K.; Angelidou, S.; Tetley, T.D.; Bittermann, A.G.; Frame, M.C.; Seckl, M.J. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell. Signal. 2007, 19, 1081–1092. [Google Scholar] [CrossRef] [PubMed]
  36. Lingwood, D.; Simons, K. Lipid Rafts As a Membrane-Organizing Principle. Science 2010, 327, 46–50. [Google Scholar] [CrossRef] [Green Version]
  37. Ahmad, F.; Sun, Q.; Patel, D.; Stommel, J.M. Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma. Cancers 2019, 11, 146. [Google Scholar] [CrossRef] [Green Version]
  38. Villa, G.R.; Hulce, J.J.; Zanca, C.; Bi, J.; Ikegami, S.; Cahill, G.L.; Gu, Y.; Lum, K.M.; Masui, K.; Yang, H. An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers. Cancer Cell 2016, 30, 683–693. [Google Scholar] [CrossRef] [Green Version]
  39. Nguyen, D.H.; Espinoza, J.C.; Taub, D.D. Cellular cholesterol enrichment impairs T cell activation and chemotaxis. Mech. Ageing Dev. 2004, 125, 641–650. [Google Scholar] [CrossRef]
  40. Folch, J.; Lees, M.; Stanley, G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [Google Scholar] [CrossRef]
  41. Beckonert, O.; Keun, H.C.; Ebbels, T.M.D.; Bundy, J.; Holmes, E.; Lindon, J.C.; Nicholson, J.K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007, 2, 2692–2703. [Google Scholar] [CrossRef] [PubMed]
  42. Zheng, W.; Reem, R.E.; Omarova, S.; Huang, S.; DiPatre, P.L.; Charvet, C.D.; Curcio, C.A.; Pikuleva, I.A. Spatial Distribution of the Pathways of Cholesterol Homeostasis in Human Retina. PLoS ONE 2012, 7, e37926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Mori, T.; Paris, D.; Town, T.; Rojiani, A.M.; Sparks, D.L.; Delledonne, A.; Crawford, F.; Abdullah, L.I.; Humphrey, J.A.; Dickson, D.W. Cholesterol Accumulates in Senile plaques of Alzheimer Disease patients and in Transgenic APPsw Mice. J. Neuropathol. Exp. Neurol. 2001, 60, 778–785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Kim, M.; Gillen, J.; Landman, B.A.; Zhou, J.; van Zijl, P.C. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn. Reson. Med. 2009, 61, 1441–1450. [Google Scholar] [CrossRef] [Green Version]
  45. Holland, E.C.; Celestino, J.; Dai, C.; Schaefer, L.; Sawaya, R.E.; Fuller, G. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 2000, 25, 55–57. [Google Scholar] [CrossRef]
  46. Lam, W.W.; Oakden, W.; Karami, E.; Koletar, M.M.; Murray, L.; Liu, S.; Sadeghi-Naini, A.; Stanisz, G.J. An Automated Segmentation Pipeline for Intratumoural Regions in Animal Xenografts Using Machine Learning and Saturation Transfer MRI. Sci. Rep. 2020, 10, 8063. [Google Scholar] [CrossRef]
  47. Stevens, M.M.; Honerkamp-Smith, A.R.; Keller, S.L. Solubility Limits of Cholesterol, Lanosterol, Ergosterol, Stigmasterol, and beta-Sitosterol in Electroformed Lipid Vesicles. Soft Matter 2010, 6, 5882–5890. [Google Scholar] [CrossRef]
  48. van Zijl, P.C.M.; Jones, C.K.; Ren, J.; Malloy, C.R.; Sherry, A.D. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc. Natl. Acad. Sci. USA 2007, 104, 4359–4364. [Google Scholar] [CrossRef] [Green Version]
  49. van Meer, G.; Voelker, D.R.; Feigenson, G.W. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9, 112–124. [Google Scholar] [CrossRef]
  50. Beljebbar, A.; Amharref, N.; Lévèques, A.; Dukic, S.; Venteo, L.; Schneider, L.; Pluot, M.; Manfait, M. Modeling and Quantifying Biochemical Changes in C6 Tumor Gliomas by Fourier Transform Infrared Imaging. Anal. Chem. 2008, 80, 8406–8415. [Google Scholar] [CrossRef]
  51. Woodruff, T.M.; Thundyil, J.; Tang, S.-C.; Sobey, C.G.; Taylor, S.M.; Arumugam, T.V. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol. Neurodegener. 2011, 6, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Kur, E.; Christa, A.; Veth, K.N.; Gajera, C.R.; Andrade-Navarro, M.A.; Zhang, J.; Willer, J.R.; Gregg, R.G.; Abdelilah-Seyfried, S.; Bachmann, S. Loss of Lrp2 in zebrafish disrupts pronephric tubular clearance but not forebrain development. Dev. Dyn. 2011, 240, 1567–1577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Gajera, C.R.; Emich, H.; Lioubinski, O.; Christ, A.; Beckervordersandforth-Bonk, R.; Yoshikawa, K.; Bachmann, S.; Christensen, E.I.; Götz, M.; Kempermann, G. LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche. J. Cell Sci. 2010, 123 Pt 11, 1922–1930. [Google Scholar] [CrossRef] [Green Version]
  54. Spuch, C.; Ortolano, S.; Navarro, C. LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer’s disease. Front. Physiol. 2012, 3, 269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Crews, L.; Adame, A.; Patrick, C.; Delaney, A.; Pham, E.; Rockenstein, E.; Hansen, L.; Masliah, E. Increased BMP6 Levels in the Brains of Alzheimer’s Disease Patients and APP Transgenic Mice Are Accompanied by Impaired Neurogenesis. J. Neurosci. 2010, 30, 12252–12262. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Average z-spectra (N = 9) from normal (blue) and tumorous (red) brain as measured on days 3 (A), 6 (B), 9 (C), and 12 (D). Shading areas indicate standard deviation resulting from animal variation. Saturation amplitude and saturation duration are 0.9 μT and 4 s, respectively.
Figure 1. Average z-spectra (N = 9) from normal (blue) and tumorous (red) brain as measured on days 3 (A), 6 (B), 9 (C), and 12 (D). Shading areas indicate standard deviation resulting from animal variation. Saturation amplitude and saturation duration are 0.9 μT and 4 s, respectively.
Biomedicines 10 01220 g001
Figure 2. Expansion of z-spectra from Figure 1 for comparative purposes (AD); the corresponding residuals of apparent exchange-dependent relaxation rate (AREXresid) are plotted from (EH), which include averaged signals (N = 9) from normal (red) and tumorous (blue) brain tissues and their standard deviations (shaded areas). Averaged AREXresid signals from (EH) are deconvoluted using a Gaussian function centered at approximately −3.5 ppm (IL), in which dashed lines indicate rNOE(−3.5) and solid lines indicate residues from deconvolutions.
Figure 2. Expansion of z-spectra from Figure 1 for comparative purposes (AD); the corresponding residuals of apparent exchange-dependent relaxation rate (AREXresid) are plotted from (EH), which include averaged signals (N = 9) from normal (red) and tumorous (blue) brain tissues and their standard deviations (shaded areas). Averaged AREXresid signals from (EH) are deconvoluted using a Gaussian function centered at approximately −3.5 ppm (IL), in which dashed lines indicate rNOE(−3.5) and solid lines indicate residues from deconvolutions.
Biomedicines 10 01220 g002
Figure 3. Longitudinal changes in magnitudes of AREXresid at −3.5 ppm (A) and −1.6 ppm (B), as extracted from Figure 2 (N = 9); longitudinal changes in area under the curve (AUC) of corresponding AREXresid at −3.5 ppm (C) and −1.6 ppm (D). (* p < 0.05, ** p < 0.001).
Figure 3. Longitudinal changes in magnitudes of AREXresid at −3.5 ppm (A) and −1.6 ppm (B), as extracted from Figure 2 (N = 9); longitudinal changes in area under the curve (AUC) of corresponding AREXresid at −3.5 ppm (C) and −1.6 ppm (D). (* p < 0.05, ** p < 0.001).
Biomedicines 10 01220 g003
Figure 4. Images of AREXresid(−1.6) (AD), hematoxylin staining (EH), and filipin staining (IL) on days 3, 6, 9, and 12. The arrows indicate the tumor regions.
Figure 4. Images of AREXresid(−1.6) (AD), hematoxylin staining (EH), and filipin staining (IL) on days 3, 6, 9, and 12. The arrows indicate the tumor regions.
Biomedicines 10 01220 g004
Figure 5. 1H NMR of cholesterol methyl (0.68 ppm) from lipid extracts of normal and tumorous brain tissues (N = 3) on days nine (A) and 12 (B) and their cholesterol content (C) as quantified using AUCs of methyl shown in (A,B). (D) The choline methyls from the phosphatidylcholines (~3.35 ppm) and alkyl hydrogens (~1.5 ppm) can be identified in the 1H spectra. The AUCs between 3.28 to 3.38 ppm and 1.45 to 1.55 ppm were used to estimate the relative amounts of phosphatidylcholine (E) and total lipid (F). (* p < 0.05).
Figure 5. 1H NMR of cholesterol methyl (0.68 ppm) from lipid extracts of normal and tumorous brain tissues (N = 3) on days nine (A) and 12 (B) and their cholesterol content (C) as quantified using AUCs of methyl shown in (A,B). (D) The choline methyls from the phosphatidylcholines (~3.35 ppm) and alkyl hydrogens (~1.5 ppm) can be identified in the 1H spectra. The AUCs between 3.28 to 3.38 ppm and 1.45 to 1.55 ppm were used to estimate the relative amounts of phosphatidylcholine (E) and total lipid (F). (* p < 0.05).
Biomedicines 10 01220 g005
Figure 6. Averaged (N = 3) z-spectra (A,D) from cholesterol-depleted (red), control (green), and cholesterol-enriched (blue) cell homogenates, corresponding AREXresid (B,E), and deconvoluted AREXresid (C,F). Standard deviations are indicated by shaded areas. Dotted lines indicate rNOE(−3.5), solid lines indicate rNOE(−1.6), and dashed lines indicate residues from deconvolutions. The CEST signals from the negative and positive regions are shown in (AC) and (DF), respectively.
Figure 6. Averaged (N = 3) z-spectra (A,D) from cholesterol-depleted (red), control (green), and cholesterol-enriched (blue) cell homogenates, corresponding AREXresid (B,E), and deconvoluted AREXresid (C,F). Standard deviations are indicated by shaded areas. Dotted lines indicate rNOE(−3.5), solid lines indicate rNOE(−1.6), and dashed lines indicate residues from deconvolutions. The CEST signals from the negative and positive regions are shown in (AC) and (DF), respectively.
Biomedicines 10 01220 g006
Figure 7. (A) Averaged 1H NMR signal (N = 3) of cholesterol methyl at 0.68 ppm from cholesterol-depleted (red), control (green), and cholesterol-enriched (blue) cell homogenates, in which standard deviations are indicated by shaded areas. Scattering plot illustrating the association between cholesterol concentration and AUCs of AREXresid(−3.5) (B) and AREXresid(−1.6) (C), in which regression is indicated by a blue line.
Figure 7. (A) Averaged 1H NMR signal (N = 3) of cholesterol methyl at 0.68 ppm from cholesterol-depleted (red), control (green), and cholesterol-enriched (blue) cell homogenates, in which standard deviations are indicated by shaded areas. Scattering plot illustrating the association between cholesterol concentration and AUCs of AREXresid(−3.5) (B) and AREXresid(−1.6) (C), in which regression is indicated by a blue line.
Biomedicines 10 01220 g007
Table 1. Regression results for associations between cholesterol concentration and area under the curve (AUC) of the residuals of apparent exchange-dependent relaxation rate (AREXresid) in lipid extracts from cell homogenates.
Table 1. Regression results for associations between cholesterol concentration and area under the curve (AUC) of the residuals of apparent exchange-dependent relaxation rate (AREXresid) in lipid extracts from cell homogenates.
Slope
(% s−1/mM)
Intercept
(% s−1)
R2
rNOE(−3.5)3.0611.480.9310
rNOE(−1.6)0.470.361.000
Amine0.975.200.9838
Amide0.452.030.9159
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wu, Q.-X.; Liu, H.-Q.; Wang, Y.-J.; Chen, T.-C.; Wei, Z.-Y.; Chang, J.-H.; Chen, T.-H.; Seema, J.; Lin, E.C. Chemical Exchange Saturation Transfer (CEST) Signal at −1.6 ppm and Its Application for Imaging a C6 Glioma Model. Biomedicines 2022, 10, 1220. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines10061220

AMA Style

Wu Q-X, Liu H-Q, Wang Y-J, Chen T-C, Wei Z-Y, Chang J-H, Chen T-H, Seema J, Lin EC. Chemical Exchange Saturation Transfer (CEST) Signal at −1.6 ppm and Its Application for Imaging a C6 Glioma Model. Biomedicines. 2022; 10(6):1220. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines10061220

Chicago/Turabian Style

Wu, Qi-Xuan, Hong-Qing Liu, Yi-Jiun Wang, Tsai-Chen Chen, Zi-Ying Wei, Jung-Hsuan Chang, Ting-Hao Chen, Jaya Seema, and Eugene C. Lin. 2022. "Chemical Exchange Saturation Transfer (CEST) Signal at −1.6 ppm and Its Application for Imaging a C6 Glioma Model" Biomedicines 10, no. 6: 1220. https://0-doi-org.brum.beds.ac.uk/10.3390/biomedicines10061220

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop